Live Nation, CTS, DEAG shares soar after vaccine news

The live industry giants saw their share prices increase by double digits yesterday after news of a 90% effective coronavirus vaccine

News By IQ | 10 November 2020

Dr Albert Bourla of Pfizer, which co-developed the vaccine
Dr Albert Bourla of Pfizer, which co-developed the vaccine © Pfizer

Live music industry behemoths including Live Nation, CTS Eventim and DEAG saw their share prices soar yesterday (9 October), following early results from the world’s first effective coronavirus vaccine which could prevent more than 90% of people from getting Covid.

Live Nation Entertainment, the world’s biggest promoter and owner of Ticketmaster, saw its share price rise by more than 22% while pan European ticketing giant CTS Eventim was up 23% and German live entertainment group DEAG’s share price also grew by…

You've used your free article this month

Continue reading with a free account, or subscribe for unlimited access to all of our news, features and reports.

Subscribe Create a Free Account

Share this

MOST POPULAR

Related Content

DEAG CEO Peter Schwenkow

The Deutsche entertainer: Peter Schwenkow

IQ learns about the DEAG founder and CEO’s path to the top and his future ambitions after 50 years in the business

Feature 27 February, 2024

International Ticketing Yearbook (ITY) 2020, IQ 95

ITY 2020: Ticketing experts gear up for recovery

From battling through lockdown to managing onsales for 2021 and beyond, it's been a hectic 12 months for ticketing professionals. Now, all eyes are on the year ahead

Feature 8 January, 2021

CTS Eventim shares are listed on the Frankfurt Stock Exchange

Public live companies grow $1bn+ per quarter since 2017

The major stock market-listed live businesses have increased their market caps by a collective $8.3bn since mid-2017 – $7bn of it this year alone

News 20 August, 2019

Back to top